Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients

Russo, Domenico; Malagola, Michele; Vivo, A; Fiacchini, M; Martinelli, G; Piccaluga, Pp; Damiani, D; Candoni, A; Michielutti, A; Castelli, M; Testoni, N; Ottaviani, E; Rondoni, M; Pricolo, G; Mazza, P; Zuffa, E; Zaccaria, A; Raspadori, D; Bocchia, M; Lauria, F; Bonini, A; Avanzini, P; Gugliotta, L; Visani, G; Fanin, R; Baccarani, M.